Literature DB >> 26629164

Serum apelin levels in patients with thyroid dysfunction.

Ali Gürel1, Akif Doğantekin2, Yusuf Özkan3, Süleyman Aydın4.   

Abstract

Adipocytes are not only for energy storage, but are also functionally active cells, producing biologically active peptides called adipocytokines. Adipocytokines control nutrition, thermogenesis, immunity, thyroid and reproductive hormones, and neuroendocrine functions. One of the most important new members of this family is apelin. In patients with thyroid dysfunctions, there are usually changes in weight, thermogenesis and adipose tissue lipolysis. Here, we investigated the serum apelin levels in different thyroid hormone states. Our study group consisted of the following patients: 32 thyrotoxicosis, 32 subclinical hyperthyroidism, 31 hypothyroidism, 34 subclinical hypothyroidism and 31 healthy control cases. In addition to routine blood tests, serum free T3 (FT3), free T4 (FT4), TSH and apelin levels were measured, and the body mass index (BMI) was recorded. In terms of the demographic characteristics, age and BMI, there was no statistically significant difference between the groups (P>0.05). The mean serum apelin levels of the groups were as follows: thyrotoxicosis group, 4.6±1.9 ng/ml; subclinical hyperthyroidism group, 3.7±1.9 ng/ml; hypothyroid group, 4.8±2.5 ng/ml; subclinical hypothyroidism group, 4.3±2.2 ng/mL; and control group, 3.4±1.4 ng/ml, respectively. There was no statistically significant difference in terms of the mean apelin levels between the groups (P>0.05). The hypothyroid group had the highest and the control group had the lowest mean apelin levels. As a result, the apelin levels were higher in both the patients with hypothyroidism and hyperthyroidism, in comparison with the normal population, but without statistical significance.

Entities:  

Keywords:  Thyroid dysfunction; apelin; metabolic disorders

Year:  2015        PMID: 26629164      PMCID: PMC4659052     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  28 in total

Review 1.  Action of thyroid hormones at the cellular level: the mitochondrial target.

Authors:  F Goglia; M Moreno; A Lanni
Journal:  FEBS Lett       Date:  1999-06-11       Impact factor: 4.124

Review 2.  Thyroid hormone and the cardiovascular system.

Authors:  I Klein; K Ojamaa
Journal:  N Engl J Med       Date:  2001-02-15       Impact factor: 91.245

3.  Laboratory medicine practice guidelines: laboratory support for the diagnosis and monitoring of thyroid disease.

Authors:  L M Demers; C A Spencer
Journal:  Clin Endocrinol (Oxf)       Date:  2003-02       Impact factor: 3.478

Review 4.  The biology of mitochondrial uncoupling proteins.

Authors:  Sophie Rousset; Marie-Clotilde Alves-Guerra; Julien Mozo; Bruno Miroux; Anne-Marie Cassard-Doulcier; Frédéric Bouillaud; Daniel Ricquier
Journal:  Diabetes       Date:  2004-02       Impact factor: 9.461

Review 5.  Adipocytokines and metabolic syndrome.

Authors:  Yuji Matsuzawa
Journal:  Semin Vasc Med       Date:  2005-02

Review 6.  Thyroid hormone and the cardiovascular system.

Authors:  I Klein
Journal:  Am J Med       Date:  1990-06       Impact factor: 4.965

7.  Effect of experimental hypo- and hyperthyroidism on serum adiponectin.

Authors:  Christina Nogueira Aragão; Luana Lopes Souza; Adriana Cabanelas; Karen Jesus Oliveira; Carmen Cabanelas Pazos-Moura
Journal:  Metabolism       Date:  2007-01       Impact factor: 8.694

8.  Apelin, the novel endogenous ligand of the orphan receptor APJ, regulates cardiac contractility.

Authors:  István Szokodi; Pasi Tavi; Gábor Földes; Sari Voutilainen-Myllylä; Mika Ilves; Heikki Tokola; Sampsa Pikkarainen; Jarkko Piuhola; Jaana Rysä; Miklós Tóth; Heikki Ruskoaho
Journal:  Circ Res       Date:  2002-09-06       Impact factor: 17.367

9.  Apelin, an APJ receptor ligand, regulates body adiposity and favors the messenger ribonucleic acid expression of uncoupling proteins in mice.

Authors:  Keiko Higuchi; Takayuki Masaki; Koro Gotoh; Seiichi Chiba; Isao Katsuragi; Katsuhiro Tanaka; Tetsuya Kakuma; Hironobu Yoshimatsu
Journal:  Endocrinology       Date:  2007-03-08       Impact factor: 4.736

Review 10.  Adipose tissues and thyroid hormones.

Authors:  Maria-Jesus Obregon
Journal:  Front Physiol       Date:  2014-12-11       Impact factor: 4.566

View more
  2 in total

1.  Secondary hormonal alterations in short-term severe hypothyroidism; in the focus: Apelin and copeptin.

Authors:  Marin Gergics; Gréta Pham-Dobor; Zoltán Horváth-Szalai; Tamás Kőszegi; Emese Mezősi; László Bajnok
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-14       Impact factor: 6.055

2.  Thyroid hormones modulate irisin concentrations in patients with recently onset hypothyroidism following total thyroidectomy.

Authors:  R Bocale; A Barini; A D'Amore; M Boscherin; S Necozione; A Barini; G Desideri; C P Lombardi
Journal:  J Endocrinol Invest       Date:  2020-10-14       Impact factor: 4.256

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.